“ab fubinaca”的搜索结果

7 个项目

每页

设置降序顺序
  1. Indeglitazar

    Catalog No. A21148
    Quick View
    PPAR agonist
    Indeglitazar is an orally available peroxisome proliferator-activated receptor (PPAR) pan-agonist for all three PPAR subtypes alpha (α), delta (δ) and gamma (γ). 了解更多
  2. Arhalofenate

    Catalog No. A21135
    Quick View
    PPARγ agonist
    Arhalofenate (MBX 102) is a selective partial agonist of peroxisome proliferator-activated receptor (PPAR)-γ, used for the treatment of type 2 diabetes. 了解更多
  3. MA-0204

    Catalog No. A19031
    Quick View
    PPARδ modulator
    MA-0204 is a potent, highly selective and orally available peroxisome proliferator activated receptor δ (PPARδ) modulator with EC50s of 0.4 nM, 7.9 nM and 10 nM for human, mouse and rat PPARδ, respectively. Potential treatment for Duchene Muscular Dystrophy (DMD). 了解更多
  4. VCE-004.8

    Catalog No. A18549
    Quick View
    PPARγ and CB2 receptor dual agonist
    VCE-004.8, a semi-synthetic multitarget cannabinoquinoid, is a specific PPARγ and CB2 receptor dual agonist with potent anti-inflammatory activity. 了解更多
  5. BR102375

    Catalog No. A18849
    Quick View
    PPAR γ agonist
    BR102375 is a non-TZD peroxisome proliferator-activated receptor γ (PPAR γ) full agonist for the treatment of type 2 diabetes, reveals EC50 value of 0.28?μM and Amax ratio?of 98%. 了解更多
  6. Choline Fenofibrate

    Catalog No. A15044
    Quick View
    CYP2C19/CYP2B6 抑制剂
    Choline Fenofibrate (ABT-335)是非诺贝特酸的胆碱盐,与瑞舒伐他汀联合用于治疗血脂异常。 了解更多
  7. Cetaben

    Catalog No. A11137
    Quick View
    Peroxisome Proliferator
    Cetaben是一种独特的,不依赖PPARα的过氧化物酶体增殖物,具有降血脂活性,可抑制人肝癌Hep-G2细胞中的胆固醇合成,从而导致高尔基体形态发生可逆变化。 了解更多

7 个项目

每页

设置降序顺序
Rewards